EU CSDR definition

EU CSDR means Regulation (EU) No. 909/2014 of the European Parliament and of the Council of 23 July 2014, as amended from time to time.
Sample 1Sample 2Sample 3

Examples of EU CSDR in a sentence

  • More information on the EU CSDR Settlement Discipline Regime can be found in the MarketGuide - EU CSDR: Settlement Discipline, published at www.six-group.com > Login> Securities Service Private > MarketGuide > Country Information > Further Market Information > EU CSDR Settlement Discipline.

  • The ECSDA Framework (market practice) is applicable to all CSDs subject to the EU CSDR or alike regulation5.

  • The ECSDA Framework (market practice) applies to all CSDs subject to the EU CSDR (text with EEA relevance) or alike regulation7.

  • The ECSDA Framework (market practice) applies to all CSDs subject to the EU CSDR (text with EEA relevance) or alike regulation9.

  • The ECSDA Framework is applicable to all CSDs subject to the EU CSDR or alike regulation4.

Related to EU CSDR

  • EU GDPR means the General Data Protection Regulation ((EU) 2016/679).

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase I Clinical Trial means the first study of a Product in humans the primary purpose of which is the determination of safety and which may include the determination of pharmacokinetic and/or pharmacodynamic profiles in healthy individuals or patients.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.